Ashani Weeraratna | |
|---|---|
| Born | Ashani Tanuja Weeraratna 1970 or 1971 (age 52–53) |
| Nationality | Sri Lankan |
| Citizenship | United States |
| Academic background | |
| Alma mater | St. Mary's College of Maryland (B.A.) George Washington University (MPhil, Ph.D.) |
| Thesis | Loss of Uteroglobin Expression in Metastatic Human Prostate Cancer (1998) |
| Doctoral advisor | Steven Patierno |
| Academic work | |
| Discipline | Cancer research |
| Sub-discipline | Melanoma metastasis |
| Institutions | Wistar Institute University of the Sciences Johns Hopkins University |
Ashani Tanuja Weeraratna (born 1970 or 1971)[1][2] is a Sri Lanka-born American cancer researcher whose findings are contributing to the scientific understanding of melanoma tumors. She is a Bloomberg Distinguished Professor of cancer biology and the E.V. McCollum Professor and Chair of the department of biochemistry and molecular biology at the Johns Hopkins Bloomberg School of Public Health. Weeraratna is a member of the National Cancer Advisory Board, which advises and assists the director of the National Cancer Institute on the activities of the national cancer program.[3]
She was head of the Weeraratna Lab at the Wistar Institute. At the Wistar Institute, Weeraratna was a full professor and co-program leader of the Immunology, Microenvironment, and Metastasis Program at the Wistar Institute and the program director of the cancer biology program at the University of the Sciences.
:0 was invoked but never defined (see the help page).:1 was invoked but never defined (see the help page).